首页 > 最新文献

American journal of medicine open最新文献

英文 中文
ST Elevation Myocardial Infarction Complicated by Cardiogenic Shock: Systematic Review of Survival Predictors ST段抬高型心肌梗死并发心源性休克:生存预测指标的系统评价
Pub Date : 2023-08-24 DOI: 10.1016/j.ajmo.2023.100057
John King Khoo MBBS, FRACP , Benjamin Peter Trewin MBBS, FRACP , Audrey Adji MB, MBiomedE, PhD , Yee Weng Wong MBBS, MHS, FRACP, FCSANZ , Sara Hungerford MBBS, FRACP, FCSANZ, PhD

Background

Cardiogenic shock complicating acute myocardial infarction is associated with reduced survival despite advancements in the treatment of acute coronary syndromes. Characterizing predictors of morbidity and mortality in this setting is crucial to improving risk stratification and management. Notwithstanding, the interplay of factors determining survival in this condition remains poorly studied.

Methods

Embase, MEDLINE, and CINAHL databases were searched for original studies evaluating predictors of short-term (30-day or in-hospital) survival in ST elevation myocardial infarction with cardiogenic shock (STEMI-CS). Included studies were analyzed by way of vote counting, identifying variables that predicted mortality or survival.

Results

Twenty-four studies, consisting of 14,735 patients (5649 nonsurvivors and 9086 survivors) were included. All studies were observational by design (17 retrospective and 7 prospective) with clinical and statistical heterogeneity. Unsuccessful revascularization, reduced left ventricular ejection fraction, renal impairment, and other variables were identified as key independent predictors of mortality.

Conclusion

Several key variables have been shown to independently increase mortality in STEMI-CS populations. Future prospective studies examining the prognostic role of multivariate scoring systems incorporating these domains are required.

背景:尽管急性冠状动脉综合征的治疗取得了进展,但心源性休克并发急性心肌梗死与生存率降低有关。在这种情况下,确定发病率和死亡率的预测因素对改善风险分层和管理至关重要。尽管如此,在这种情况下,决定生存的因素的相互作用仍然很少被研究。方法检索sembase、MEDLINE和CINAHL数据库,寻找评估ST段抬高型心肌梗死合并心源性休克(STEMI-CS)短期(30天或住院)生存预测因素的原始研究。纳入的研究通过计票的方式进行分析,确定预测死亡率或存活率的变量。结果共纳入24项研究,14735例患者(非幸存者5649例,幸存者9086例)。所有研究均设计为观察性研究(17项回顾性研究和7项前瞻性研究),具有临床和统计学异质性。血运重建失败、左室射血分数降低、肾功能损害和其他变量被确定为死亡率的关键独立预测因素。几个关键变量已被证明独立地增加STEMI-CS人群的死亡率。未来的前瞻性研究检查多变量评分系统纳入这些领域的预后作用是必要的。
{"title":"ST Elevation Myocardial Infarction Complicated by Cardiogenic Shock: Systematic Review of Survival Predictors","authors":"John King Khoo MBBS, FRACP ,&nbsp;Benjamin Peter Trewin MBBS, FRACP ,&nbsp;Audrey Adji MB, MBiomedE, PhD ,&nbsp;Yee Weng Wong MBBS, MHS, FRACP, FCSANZ ,&nbsp;Sara Hungerford MBBS, FRACP, FCSANZ, PhD","doi":"10.1016/j.ajmo.2023.100057","DOIUrl":"10.1016/j.ajmo.2023.100057","url":null,"abstract":"<div><h3>Background</h3><p>Cardiogenic shock complicating acute myocardial infarction is associated with reduced survival despite advancements in the treatment of acute coronary syndromes. Characterizing predictors of morbidity and mortality in this setting is crucial to improving risk stratification and management. Notwithstanding, the interplay of factors determining survival in this condition remains poorly studied.</p></div><div><h3>Methods</h3><p>Embase, MEDLINE, and CINAHL databases were searched for original studies evaluating predictors of short-term (30-day or in-hospital) survival in ST elevation myocardial infarction with cardiogenic shock (STEMI-CS). Included studies were analyzed by way of vote counting, identifying variables that predicted mortality or survival.</p></div><div><h3>Results</h3><p>Twenty-four studies, consisting of 14,735 patients (5649 nonsurvivors and 9086 survivors) were included. All studies were observational by design (17 retrospective and 7 prospective) with clinical and statistical heterogeneity. Unsuccessful revascularization, reduced left ventricular ejection fraction, renal impairment, and other variables were identified as key independent predictors of mortality.</p></div><div><h3>Conclusion</h3><p>Several key variables have been shown to independently increase mortality in STEMI-CS populations. Future prospective studies examining the prognostic role of multivariate scoring systems incorporating these domains are required.</p></div>","PeriodicalId":72168,"journal":{"name":"American journal of medicine open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42067215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health-Related Quality of Life Improves in Parallel with FEV1 and 6-Minute Walking Distance Test at Between 3 and 12 Months in Critical COVID-19 Survivors 新冠肺炎危重幸存者在3至12个月期间,与健康相关的生活质量与FEV1和6分钟步行距离测试同时改善
Pub Date : 2023-08-23 DOI: 10.1016/j.ajmo.2023.100055
Stephanie André , Anne-Violette Bruyneel , Audrey Chirumberro , Alain Roman , Marc Claus , Stephane Alard , Nathalie De Vos , Marie Bruyneel

Background

In COVID-19 intensive care unit (ICU)–admitted patients, multiorgan acute complications lead to long-lasting sequelae. The aim of this study was to assess (1) changes in chest CT, pulmonary function test (PFT), functional capacity (6-minute walking distance test (6MWT)), and health-related quality of life (HR-QoL) among ICU COVID-19 survivors at 3, 6, and 12 months after ICU discharge and (2) predictors of persistent impairment/improvement in 6MWT and HR-QoL.

Methods

ICU COVID-19 survivors were prospectively included. Outcomes at 3, 6, and 12 months included PFT, 6MWT, respiratory muscle strength (RMS), HR-QoL (SF-36), Medical Research Council dyspnea scale (mMRC), and post-COVID Functional Status scale.

Results

Eighty-seven survivors were included, from June 3, 2020, to September 2, 2021. At 12 months, 50% of PFT were normal, 46% were restrictive, and 22% showed reduced diffusing capacity for carbon monoxide (DLCO). Impaired DLCO was associated with ICU length of stay and age. In mixed linear model analysis, improvements in RMS and mMRC persisted over time regardless of the adjustments applied (P ≤ .050). SF-36 improved in parallel with FEV1 and 6MWT between 3 and 12 months (P ≤ .044), while increment in DLCO correlated with changes in FEV1 and total lung capacity (TLC) (p ≤ 0.026).

Conclusions

This longitudinal study demonstrated that improvements in SF-36 occur in parallel with improvements in FEV1 and 6MWT between 3 and 12 months post-ICU discharge in a sample of critically ill COVID-19 patients. However, PFT remained, however, abnormal in 50% of patients. Based on continued improvements observed from 3 to 12 months, it is anticipated that COVID-19 ICU patients will continue to recover similarly to ARDS patients.

在COVID-19重症监护病房(ICU)住院患者中,多器官急性并发症可导致长期后遗症。本研究的目的是评估(1)ICU COVID-19幸存者在出院后3、6和12个月的胸部CT、肺功能测试(PFT)、功能能力(6分钟步行距离测试(6MWT))和健康相关生活质量(HR-QoL)的变化,以及(2)6MWT和HR-QoL持续损害/改善的预测因素。方法前瞻性纳入u COVID-19幸存者。3、6和12个月的结果包括PFT、6MWT、呼吸肌力量(RMS)、HR-QoL (SF-36)、医学研究委员会呼吸困难量表(mMRC)和covid后功能状态量表。结果2020年6月3日至2021年9月2日,纳入幸存者87例。12个月时,50%的PFT是正常的,46%是限制性的,22%显示一氧化碳扩散能力(DLCO)降低。DLCO受损与ICU住院时间和年龄有关。在混合线性模型分析中,无论采用何种调整,RMS和mMRC的改善都会持续一段时间(P≤0.050)。SF-36与FEV1和6MWT在3 ~ 12个月间平行改善(P≤0.044),DLCO的增加与FEV1和总肺活量(TLC)的变化相关(P≤0.026)。这项纵向研究表明,在COVID-19危重患者样本中,在icu出院后3至12个月内,SF-36的改善与FEV1和6MWT的改善同时发生。然而,50%的患者PFT仍然异常。根据3至12个月观察到的持续改善,预计COVID-19 ICU患者将继续与ARDS患者类似地恢复。
{"title":"Health-Related Quality of Life Improves in Parallel with FEV1 and 6-Minute Walking Distance Test at Between 3 and 12 Months in Critical COVID-19 Survivors","authors":"Stephanie André ,&nbsp;Anne-Violette Bruyneel ,&nbsp;Audrey Chirumberro ,&nbsp;Alain Roman ,&nbsp;Marc Claus ,&nbsp;Stephane Alard ,&nbsp;Nathalie De Vos ,&nbsp;Marie Bruyneel","doi":"10.1016/j.ajmo.2023.100055","DOIUrl":"10.1016/j.ajmo.2023.100055","url":null,"abstract":"<div><h3>Background</h3><p>In COVID-19 intensive care unit (ICU)–admitted patients, multiorgan acute complications lead to long-lasting sequelae. The aim of this study was to assess (1) changes in chest CT, pulmonary function test (PFT), functional capacity (6-minute walking distance test (6MWT)), and health-related quality of life (HR-QoL) among ICU COVID-19 survivors at 3, 6, and 12 months after ICU discharge and (2) predictors of persistent impairment/improvement in 6MWT and HR-QoL.</p></div><div><h3>Methods</h3><p>ICU COVID-19 survivors were prospectively included. Outcomes at 3, 6, and 12 months included PFT, 6MWT, respiratory muscle strength (RMS), HR-QoL (SF-36), Medical Research Council dyspnea scale (mMRC), and post-COVID Functional Status scale.</p></div><div><h3>Results</h3><p>Eighty-seven survivors were included, from June 3, 2020, to September 2, 2021. At 12 months, 50% of PFT were normal, 46% were restrictive, and 22% showed reduced diffusing capacity for carbon monoxide (DLCO). Impaired DLCO was associated with ICU length of stay and age. In mixed linear model analysis, improvements in RMS and mMRC persisted over time regardless of the adjustments applied (<em>P</em> ≤ .050). SF-36 improved in parallel with FEV1 and 6MWT between 3 and 12 months (<em>P</em> ≤ .044), while increment in DLCO correlated with changes in FEV1 and total lung capacity (TLC) (<em>p</em> ≤ 0.026).</p></div><div><h3>Conclusions</h3><p>This longitudinal study demonstrated that improvements in SF-36 occur in parallel with improvements in FEV1 and 6MWT between 3 and 12 months post-ICU discharge in a sample of critically ill COVID-19 patients. However, PFT remained, however, abnormal in 50% of patients. Based on continued improvements observed from 3 to 12 months, it is anticipated that COVID-19 ICU patients will continue to recover similarly to ARDS patients.</p></div>","PeriodicalId":72168,"journal":{"name":"American journal of medicine open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48544920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is the SIRS Criteria a Good Predictor of Blood stream Infection in Cirrhosis? A Single-Center Retrospective Analysis SIRS标准是肝硬化血流感染的良好预测指标吗?单中心回顾性分析
Pub Date : 2023-08-02 DOI: 10.1016/j.ajmo.2023.100052
Nandakumar Mohan , Samir Shah , Atif Nehvi , Edward Bley , Kevin Bryan Lo , Sarah Perloff

Introduction

Cirrhosis-associated immune dysfunction (CAID) is a chronic vasodilatory state with hyperdynamic circulation and alterations in thermoregulation that may make patients more susceptible to and mask underlying infection. This study aims to determine whether SIRS criteria are an accurate tool for predicting bloodstream infection (BSI) in cirrhosis.

Methods

In our retrospective chart review, study population included patients with cirrhosis that were 18 years or older. For all study patients, model for end-stage liver disease (MELD) scores and values for each SIRS variable at the time of admission and blood culture data were recorded. Univariable and multivariable logistic regression analysis was performed to identify any associations between dichotomized SIRS variables that fulfill SIRS positivity and BSI.

Results

Significantly more patients without BSI met positivity criteria for WBC counts (30% vs 13% p < .001). In the analysis of the SIRS variables as continuous variables in prediction of BSI, the AUC curves generated were all unsatisfactory with the temperature (36-38°C) and WBC count (4 × 103 to 12 × 103 mcL) at the time of admission having the highest areas under the ROC curve (0.52 and 0.55, respectively). Looking at the SIRS variables dichotomized (according to whether fulfilling SIRS criteria or not) in univariable logistic regression, only WBC counts meeting SIRS criteria were significantly associated with BSI OR 0.37 (0.18-0.77); p = .008, but this was an inverse association. This association was true even in the multivariable model OR 0.38 (0.18-0.80); p = .01.

Conclusion

Our study shows that SIRS criteria are a poor predictor of BSI among patients with cirrhosis.

肝硬化相关免疫功能障碍(CAID)是一种慢性血管舒张状态,伴有高动力循环和体温调节的改变,这可能使患者更容易感染并掩盖潜在的感染。本研究旨在确定SIRS标准是否是预测肝硬化血流感染(BSI)的准确工具。方法在我们的回顾性图表回顾中,研究人群包括18岁及以上的肝硬化患者。对于所有研究患者,记录入院时终末期肝病模型(MELD)评分和每个SIRS变量的值以及血培养数据。采用单变量和多变量logistic回归分析来确定SIRS阳性的二分类SIRS变量与BSI之间的关联。结果:无BSI患者WBC计数符合阳性标准的患者明显增多(30% vs 13% p <措施)。在将SIRS变量作为预测BSI的连续变量进行分析时,所生成的AUC曲线均不理想,入院时的温度(36 ~ 38℃)和白细胞计数(4 × 103 ~ 12 × 103 mcL)的ROC曲线下面积最大(分别为0.52和0.55)。单变量logistic回归中SIRS变量二分类(根据是否满足SIRS标准),只有符合SIRS标准的WBC计数与BSI显著相关or为0.37 (0.18-0.77);P = 0.008,但这是负相关。即使在多变量模型中,这种关联也是成立的OR为0.38 (0.18-0.80);p = 0.01。结论我们的研究表明SIRS标准不能很好地预测肝硬化患者的BSI。
{"title":"Is the SIRS Criteria a Good Predictor of Blood stream Infection in Cirrhosis? A Single-Center Retrospective Analysis","authors":"Nandakumar Mohan ,&nbsp;Samir Shah ,&nbsp;Atif Nehvi ,&nbsp;Edward Bley ,&nbsp;Kevin Bryan Lo ,&nbsp;Sarah Perloff","doi":"10.1016/j.ajmo.2023.100052","DOIUrl":"10.1016/j.ajmo.2023.100052","url":null,"abstract":"<div><h3>Introduction</h3><p>Cirrhosis-associated immune dysfunction (CAID) is a chronic vasodilatory state with hyperdynamic circulation and alterations in thermoregulation that may make patients more susceptible to and mask underlying infection. This study aims to determine whether SIRS criteria are an accurate tool for predicting bloodstream infection (BSI) in cirrhosis.</p></div><div><h3>Methods</h3><p>In our retrospective chart review, study population included patients with cirrhosis that were 18 years or older. For all study patients, model for end-stage liver disease (MELD) scores and values for each SIRS variable at the time of admission and blood culture data were recorded. Univariable and multivariable logistic regression analysis was performed to identify any associations between dichotomized SIRS variables that fulfill SIRS positivity and BSI.</p></div><div><h3>Results</h3><p>Significantly more patients without BSI met positivity criteria for WBC counts (30% vs 13% <em>p</em> &lt; .001). In the analysis of the SIRS variables as continuous variables in prediction of BSI, the AUC curves generated were all unsatisfactory with the temperature (36-38°C) and WBC count (4 × 10<sup>3</sup> to 12 × 10<sup>3</sup> mcL) at the time of admission having the highest areas under the ROC curve (0.52 and 0.55, respectively). Looking at the SIRS variables dichotomized (according to whether fulfilling SIRS criteria or not) in univariable logistic regression, only WBC counts meeting SIRS criteria were significantly associated with BSI OR 0.37 (0.18-0.77); <em>p</em> = .008, but this was an inverse association. This association was true even in the multivariable model OR 0.38 (0.18-0.80); <em>p</em> = .01.</p></div><div><h3>Conclusion</h3><p>Our study shows that SIRS criteria are a poor predictor of BSI among patients with cirrhosis.</p></div>","PeriodicalId":72168,"journal":{"name":"American journal of medicine open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43022180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nephrologist-Led Simulation-Based Focused Cardiac Ultrasound Workshop for Medical Students: Insights and Implications 肾病学家领导的医学生模拟聚焦心脏超声研讨会:见解和启示
Pub Date : 2023-07-20 DOI: 10.1016/j.ajmo.2023.100051
Abhilash Koratala , Hari R. Paudel , Kevin R. Regner

Background

Point-of-care ultrasonography (POCUS) is being increasingly recognized as an adjunct to physical examination. However, limited availability of trained faculty in specialties other than emergency medicine and lack of universal training standards remain key barriers to its widespread integration into undergraduate and graduate medical curricula. In this study, we sought to explore the effectiveness of a short simulation-based workshop for medical students teaching basic cardiac ultrasound led by a nephrologist.

Methods

Workshops were conducted for 2 different groups of 4th-year medical students with a total of 25 attendees. The workshop consisted of a 1-hour lecture followed by 15 minutes of cardiac anatomy simulation and a 2- to 2.5-hour hands-on session in the simulation laboratory. An anonymous precourse questionnaire comprising 10 questions assessing the interpretation of common grayscale ultrasound findings encountered in patients with undifferentiated hypotension was performed. After the workshop, a postcourse exam and survey were conducted, retesting the same concepts and seeking the students’ feedback on the course.

Results

In total, 23 and 20 students answered the pre- and postcourse surveys, respectively. The mean total score on the pretest was 63.8% ± 13.6%, which significantly increased to 91.5% ± 10.5% on the posttest (P < .001). About 90% of the respondents strongly agreed that the cardiac anatomy simulation improved their understanding of the cardiac sonographic anatomy; 75% strongly agreed that the hands-on simulation enhanced their confidence in image acquisition and interpretation; and 70% said they would choose nephrology elective if POCUS training was integrated with it.

Conclusions

A nephrologist-led diagnostic POCUS workshop using simulation techniques is effective in improving the learners’ knowledge, understanding of the sonographic cardiac anatomy, and confidence in image acquisition. Integration of POCUS training may increase medical student interest in nephrology elective rotations.

背景:即时超声检查(POCUS)越来越被认为是身体检查的辅助手段。然而,急诊医学以外专业训练有素的教师数量有限,缺乏普遍的培训标准,仍然是将其广泛纳入本科和研究生医学课程的主要障碍。在这项研究中,我们试图探索由肾病专家领导的以模拟为基础的短期医学学生心脏超声教学研讨会的有效性。方法对两组四年级医学生进行研讨会,共25人参加。研讨会包括1小时的讲座,随后是15分钟的心脏解剖模拟和2至2.5小时的模拟实验室实践环节。一份包含10个问题的匿名术前问卷评估了未分化性低血压患者常见的灰度超声结果的解释。工作坊结束后,进行了课后考试和调查,重新测试相同的概念,并寻求学生对课程的反馈。结果共有23名学生参加了课前调查,20名学生参加了课后调查。前测平均总分为63.8%±13.6%,后测平均总分为91.5%±10.5% (P <措施)。约90%的受访者强烈同意心脏解剖模拟提高了他们对心脏超声解剖的理解;75%的人强烈同意,动手模拟增强了他们对图像采集和解释的信心;70%的人表示,如果POCUS培训与之相结合,他们会选择肾脏病选修课。结论肾内科医生主导的POCUS模拟诊断研习班能够有效提高学习者对超声心脏解剖的认识和理解,增强图像采集的信心。整合POCUS训练可能会增加医学生对肾脏学选修轮转的兴趣。
{"title":"Nephrologist-Led Simulation-Based Focused Cardiac Ultrasound Workshop for Medical Students: Insights and Implications","authors":"Abhilash Koratala ,&nbsp;Hari R. Paudel ,&nbsp;Kevin R. Regner","doi":"10.1016/j.ajmo.2023.100051","DOIUrl":"10.1016/j.ajmo.2023.100051","url":null,"abstract":"<div><h3>Background</h3><p>Point-of-care ultrasonography (POCUS) is being increasingly recognized as an adjunct to physical examination. However, limited availability of trained faculty in specialties other than emergency medicine and lack of universal training standards remain key barriers to its widespread integration into undergraduate and graduate medical curricula. In this study, we sought to explore the effectiveness of a short simulation-based workshop for medical students teaching basic cardiac ultrasound led by a nephrologist.</p></div><div><h3>Methods</h3><p>Workshops were conducted for 2 different groups of 4th-year medical students with a total of 25 attendees. The workshop consisted of a 1-hour lecture followed by 15 minutes of cardiac anatomy simulation and a 2- to 2.5-hour hands-on session in the simulation laboratory. An anonymous precourse questionnaire comprising 10 questions assessing the interpretation of common grayscale ultrasound findings encountered in patients with undifferentiated hypotension was performed. After the workshop, a postcourse exam and survey were conducted, retesting the same concepts and seeking the students’ feedback on the course.</p></div><div><h3>Results</h3><p>In total, 23 and 20 students answered the pre- and postcourse surveys, respectively. The mean total score on the pretest was 63.8% ± 13.6%, which significantly increased to 91.5% ± 10.5% on the posttest (<em>P</em> &lt; .001). About 90% of the respondents strongly agreed that the cardiac anatomy simulation improved their understanding of the cardiac sonographic anatomy; 75% strongly agreed that the hands-on simulation enhanced their confidence in image acquisition and interpretation; and 70% said they would choose nephrology elective if POCUS training was integrated with it.</p></div><div><h3>Conclusions</h3><p>A nephrologist-led diagnostic POCUS workshop using simulation techniques is effective in improving the learners’ knowledge, understanding of the sonographic cardiac anatomy, and confidence in image acquisition. Integration of POCUS training may increase medical student interest in nephrology elective rotations.</p></div>","PeriodicalId":72168,"journal":{"name":"American journal of medicine open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45006862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Significance of Quantitative Viral Load in Patients Positive for SARS-CoV-2 严重急性呼吸系统综合征冠状病毒2型阳性患者定量病毒载量的临床意义
Pub Date : 2023-07-11 DOI: 10.1016/j.ajmo.2023.100050
Shannon W. Finks, Edward Van Matre, William Budd, Elizabeth Lemley, N. Katherine Ray, Madeline Mahon, Erin Chambers, A. Lloyd Finks

Cycle threshold (CT) refers to the number of cycles in a reverse transcriptase polymerase chain reaction (RT-PCR) assay needed to amplify viral RNA and can be used to indicate viral load. CT is inversely related to viral load, where lower CT values indicate higher viral levels. Data suggest lower CT scores are associated with worse outcomes in COVID; however, quantitative CT scores are not typically reported to patients. This retrospective analysis examined the use of CT scores in patient counseling for positive COVID results and suggests that higher viral loads were associated with greater need for prescription drug therapy in the outpatient setting. Patient perception of CT score was found to influence masking and quarantine behavior. We hypothesize that a quantitative threshold for viral load such as CT can be useful in patient counseling, estimating need for drug therapy, and influencing behavior toward public health concerns.

周期阈值(CT)是指逆转录酶聚合酶链反应(RT-PCR)检测中扩增病毒RNA所需的周期数,可用于指示病毒载量。CT值与病毒载量呈负相关,CT值越低表明病毒水平越高。数据显示,CT评分较低与COVID的预后较差相关;然而,定量CT评分通常不报告给患者。这项回顾性分析检查了CT评分在患者COVID阳性结果咨询中的使用情况,并表明更高的病毒载量与门诊环境中更大的处方药治疗需求相关。发现患者对CT评分的感知会影响掩蔽和隔离行为。我们假设,病毒载量的定量阈值,如CT,可用于患者咨询,估计药物治疗的需求,并影响公众健康问题的行为。
{"title":"Clinical Significance of Quantitative Viral Load in Patients Positive for SARS-CoV-2","authors":"Shannon W. Finks,&nbsp;Edward Van Matre,&nbsp;William Budd,&nbsp;Elizabeth Lemley,&nbsp;N. Katherine Ray,&nbsp;Madeline Mahon,&nbsp;Erin Chambers,&nbsp;A. Lloyd Finks","doi":"10.1016/j.ajmo.2023.100050","DOIUrl":"10.1016/j.ajmo.2023.100050","url":null,"abstract":"<div><p>Cycle threshold (CT) refers to the number of cycles in a reverse transcriptase polymerase chain reaction (RT-PCR) assay needed to amplify viral RNA and can be used to indicate viral load. CT is inversely related to viral load, where lower CT values indicate higher viral levels. Data suggest lower CT scores are associated with worse outcomes in COVID; however, quantitative CT scores are not typically reported to patients. This retrospective analysis examined the use of CT scores in patient counseling for positive COVID results and suggests that higher viral loads were associated with greater need for prescription drug therapy in the outpatient setting. Patient perception of CT score was found to influence masking and quarantine behavior. We hypothesize that a quantitative threshold for viral load such as CT can be useful in patient counseling, estimating need for drug therapy, and influencing behavior toward public health concerns.</p></div>","PeriodicalId":72168,"journal":{"name":"American journal of medicine open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43692669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patterns of Digoxin Prescribing for Medicare Beneficiaries in the United States 2013-2019 2013-2019年美国医疗保险受益人地高辛处方模式
Pub Date : 2023-06-24 DOI: 10.1016/j.ajmo.2023.100048
Claudia See , Kevin M. Wheelock , César Caraballo , Rohan Khera , Amarnath Annapureddy , Shiwani Mahajan , Yuan Lu , Harlan M. Krumholz , Karthik Murugiah

Background

Studies show that digoxin use is declining but is still prevalent. Recent data on digoxin prescription and characteristics of digoxin prescribers are unknown, which can help understand its contemporary use.

Methods

Using Medicare Part D data from 2013 to 2019, we studied the change in number and proportion of digoxin prescriptions and digoxin prescribers, overall and by specialty. Using logistic regression, we identified prescriber characteristics associated with digoxin prescription.

Results

From 2013 to 2019, total digoxin prescriptions (4.6 to 1.8 million) and proportion of digoxin prescribers decreased (9.1% to 4.3% overall; 26.6% to 11.8% among General Medicine prescribers and 65.4% to 48.9% among Cardiology). Of digoxin prescribers from 2013 practicing in 2019 (91.2% remained active), 59.1% did not prescribe digoxin at all, 31.7% reduced, and 9.2% maintained or increased prescriptions. The proportion of all digoxin prescriptions that were prescribed by General Medicine prescribers declined from 59.7% to 48.2% and increased for Cardiology (29% to 38.5%). Among new prescribers in 2019 (N = 85,508), only 1.9% prescribed digoxin. Digoxin prescribers when compared to non–digoxin prescribers were more likely male, graduated from medical school earlier, were located in the Midwest or South, and belonged to Cardiology (all P < .001).

Conclusions

Digoxin prescriptions continue to decline with over half of 2013 prescribers no longer prescribing digoxin in 2019. This may be a result of the increasing availability of newer heart failure therapies. The decline in digoxin prescription was greater among general medicine physicians than cardiologists, suggesting a change in digoxin use to a medication prescribed increasingly by specialists.

研究表明地高辛的使用正在下降,但仍然很普遍。地高辛处方的最新数据和地高辛处方者的特征尚不清楚,这有助于了解其当代使用情况。方法利用2013 - 2019年美国联邦医疗保险D部分数据,研究地高辛处方和地高辛处方者数量和比例的变化情况,分为整体和专科。使用逻辑回归,我们确定了与地高辛处方相关的处方者特征。结果2013 - 2019年,地高辛处方总量(460万~ 180万张)和处方占比总体下降(9.1% ~ 4.3%);在普通医学处方者中占26.6%至11.8%,在心脏病科处方者中占65.4%至48.9%)。在2019年执业的2013年地高辛处方者中(91.2%仍然活跃),59.1%根本不开地高辛处方,31.7%减少,9.2%维持或增加处方。普通内科处方医师开具地高辛处方的比例从59.7%下降到48.2%,心脏病科处方比例从29%上升到38.5%。在2019年的新开处方者中(N = 85,508),只有1.9%的人开地高辛。与非地高辛处方者相比,地高辛处方者更可能是男性,较早毕业于医学院,位于中西部或南部,属于心脏病学(所有P <措施)。结论地高辛处方持续减少,2013年处方者中有一半以上在2019年不再使用地高辛。这可能是新型心力衰竭治疗方法日益普及的结果。地高辛处方的减少在全科医生中比心脏病专家中更大,这表明地高辛的使用越来越多地由专科医生开处方。
{"title":"Patterns of Digoxin Prescribing for Medicare Beneficiaries in the United States 2013-2019","authors":"Claudia See ,&nbsp;Kevin M. Wheelock ,&nbsp;César Caraballo ,&nbsp;Rohan Khera ,&nbsp;Amarnath Annapureddy ,&nbsp;Shiwani Mahajan ,&nbsp;Yuan Lu ,&nbsp;Harlan M. Krumholz ,&nbsp;Karthik Murugiah","doi":"10.1016/j.ajmo.2023.100048","DOIUrl":"10.1016/j.ajmo.2023.100048","url":null,"abstract":"<div><h3>Background</h3><p>Studies show that digoxin use is declining but is still prevalent. Recent data on digoxin prescription and characteristics of digoxin prescribers are unknown, which can help understand its contemporary use.</p></div><div><h3>Methods</h3><p>Using Medicare Part D data from 2013 to 2019, we studied the change in number and proportion of digoxin prescriptions and digoxin prescribers, overall and by specialty. Using logistic regression, we identified prescriber characteristics associated with digoxin prescription.</p></div><div><h3>Results</h3><p>From 2013 to 2019, total digoxin prescriptions (4.6 to 1.8 million) and proportion of digoxin prescribers decreased (9.1% to 4.3% overall; 26.6% to 11.8% among General Medicine prescribers and 65.4% to 48.9% among Cardiology). Of digoxin prescribers from 2013 practicing in 2019 (91.2% remained active), 59.1% did not prescribe digoxin at all, 31.7% reduced, and 9.2% maintained or increased prescriptions. The proportion of all digoxin prescriptions that were prescribed by General Medicine prescribers declined from 59.7% to 48.2% and increased for Cardiology (29% to 38.5%). Among new prescribers in 2019 (<em>N</em> = 85,508), only 1.9% prescribed digoxin. Digoxin prescribers when compared to non–digoxin prescribers were more likely male, graduated from medical school earlier, were located in the Midwest or South, and belonged to Cardiology (all <em>P</em> &lt; .001).</p></div><div><h3>Conclusions</h3><p>Digoxin prescriptions continue to decline with over half of 2013 prescribers no longer prescribing digoxin in 2019. This may be a result of the increasing availability of newer heart failure therapies. The decline in digoxin prescription was greater among general medicine physicians than cardiologists, suggesting a change in digoxin use to a medication prescribed increasingly by specialists.</p></div>","PeriodicalId":72168,"journal":{"name":"American journal of medicine open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42025200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Factors Associated with Prehypertension and Hypertension Among Adults: Baseline Findings of PURE Malaysia Cohort Study 成人高血压前期和高血压的患病率和相关因素:PURE马来西亚队列研究的基线结果
Pub Date : 2023-06-23 DOI: 10.1016/j.ajmo.2023.100049
Rosnah Ismail , Noor Hassim Ismail , Zaleha Md Isa , Azmi Mohd Tamil , Mohd Hasni Ja'afar , Nafiza Mat Nasir , Suraya Abdul-Razak , Najihah Zainol Abidin , Nurul Hafiza Ab Razak , Philip Joseph , Khairul Hazdi Yusof

Background

Although prehypertension and hypertension can be detected at the primary healthcare level and low-cost treatments can effectively control its complications, hypertension is still the world's leading preventable risk factor. Therefore, the present study aimed to determine its prevalence and its risk factors among Malaysian adults.

Methods

A cross-sectional study involving 7585 adults was performed covering the rural and urban areas. Respondents with systolic blood pressure (SBP) of 120-139 mmHg and/or diastolic blood pressure (DBP) of 80-89 mmHg were categorized as prehypertensive, and hypertensive categorization was used for respondents with an SBP of ≥140 mmHg and/or DBP of ≥90 mmHg.

Results

Respondents reported to have prehypertension and hypertension were 40.7% and 38.0%, respectively. Those residing in a rural area, older age, male, family history of hypertension, and overweight or obese were associated with higher odds of prehypertension and hypertension. Unique to hypertension, the factors included low educational level (AOR: 1.349; 95% CI: 1.146, 1.588), unemployment (1.350; 1.16, 1.572), comorbidity of diabetes (1.474; 1.178, 1.844), and inadequate fruit consumption (1.253; 1.094, 1.436).

Conclusions

As the prehypertensive state may affect the prevalence of hypertension, proactive strategies are needed to increase early detection of the disease among specific group of those residing in a rural area, older age, male, family history of hypertension, and overweight or obese.

虽然高血压前期和高血压可以在初级卫生保健层面被发现,并且低成本的治疗可以有效地控制其并发症,但高血压仍然是世界上主要的可预防的危险因素。因此,本研究旨在确定其在马来西亚成年人中的患病率及其危险因素。方法采用横断面研究方法,对农村和城市地区的7585名成年人进行调查。收缩压(SBP)为120-139 mmHg和/或舒张压(DBP)为80-89 mmHg的受访者被归类为高血压前期,收缩压≥140 mmHg和/或舒张压≥90 mmHg的受访者被分类为高血压。结果高血压前期和高血压发生率分别为40.7%和38.0%。居住在农村地区、年龄较大、男性、高血压家族史、超重或肥胖的人患高血压前期和高血压的几率较高。高血压特有的影响因素包括文化程度低(AOR: 1.349;95% CI: 1.146, 1.588),失业率(1.350;1.16, 1.572),糖尿病合并症(1.474;1.178, 1.844),水果摄入不足(1.253;1.094, 1.436)。结论高血压前期状态可能影响高血压的患病率,在农村、老年、男性、高血压家族史、超重或肥胖的特定人群中,需要采取积极的策略来提高对高血压的早期发现。
{"title":"Prevalence and Factors Associated with Prehypertension and Hypertension Among Adults: Baseline Findings of PURE Malaysia Cohort Study","authors":"Rosnah Ismail ,&nbsp;Noor Hassim Ismail ,&nbsp;Zaleha Md Isa ,&nbsp;Azmi Mohd Tamil ,&nbsp;Mohd Hasni Ja'afar ,&nbsp;Nafiza Mat Nasir ,&nbsp;Suraya Abdul-Razak ,&nbsp;Najihah Zainol Abidin ,&nbsp;Nurul Hafiza Ab Razak ,&nbsp;Philip Joseph ,&nbsp;Khairul Hazdi Yusof","doi":"10.1016/j.ajmo.2023.100049","DOIUrl":"10.1016/j.ajmo.2023.100049","url":null,"abstract":"<div><h3>Background</h3><p>Although prehypertension and hypertension can be detected at the primary healthcare level and low-cost treatments can effectively control its complications, hypertension is still the world's leading preventable risk factor. Therefore, the present study aimed to determine its prevalence and its risk factors among Malaysian adults.</p></div><div><h3>Methods</h3><p>A cross-sectional study involving 7585 adults was performed covering the rural and urban areas. Respondents with systolic blood pressure (SBP) of 120-139 mmHg and/or diastolic blood pressure (DBP) of 80-89 mmHg were categorized as prehypertensive, and hypertensive categorization was used for respondents with an SBP of ≥140 mmHg and/or DBP of ≥90 mmHg.</p></div><div><h3>Results</h3><p>Respondents reported to have prehypertension and hypertension were 40.7% and 38.0%, respectively. Those residing in a rural area, older age, male, family history of hypertension, and overweight or obese were associated with higher odds of prehypertension and hypertension. Unique to hypertension, the factors included low educational level (AOR: 1.349; 95% CI: 1.146, 1.588), unemployment (1.350; 1.16, 1.572), comorbidity of diabetes (1.474; 1.178, 1.844), and inadequate fruit consumption (1.253; 1.094, 1.436).</p></div><div><h3>Conclusions</h3><p>As the prehypertensive state may affect the prevalence of hypertension, proactive strategies are needed to increase early detection of the disease among specific group of those residing in a rural area, older age, male, family history of hypertension, and overweight or obese.</p></div>","PeriodicalId":72168,"journal":{"name":"American journal of medicine open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46528268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Social Determinants of Health in Women With Heart Failure: Prospective Observational Cohort Study 心衰妇女健康的社会决定因素:前瞻性观察队列研究
Pub Date : 2023-06-12 DOI: 10.1016/j.ajmo.2023.100047
Dae Hyun Lee , Vidhi Patel , Nicholas Mencer , Sasha Ann East , Nhi Tran , Theresa Beckie , Janice Zgibor , Joel Fernandez

Objective

The social determinants of health (SDoH) account for 80%-90% of modifiable contributors to health outcomes for chronic diseases such as heart failure. Knowledge gaps exist on how SDoH influences hospitalization rates in women with heart failure. Our aim was to evaluate the relationship between the baseline SDoH status of women with heart failure with subsequent all-cause and cardiovascular hospitalization.

Methods

This is a prospective observational longitudinal cohort study of women diagnosed with heart failure with 6-month follow-up. The subjects completed SDoH assessment by the Institute of Medicine. Monthly follow-ups were performed to assess for hospitalization events.

Results

A total of 92 patients with at least 1 follow-up clinic visit were included. The mean age was 66 ± 15 years and 80% had nonischemic cardiomyopathy as the etiology of heart failure. New York Heart Association (NYHA) Classifications I-II were the most common (n = 66, 71.8%). In total, 51 patients (55.4%) had overall high-risk SDoH (4 or more SDoH domains at risk). By the 6-month follow-up, 22 (23.9%) patients were hospitalized for any cause; 8 patients (8.7%) were hospitalized for cardiovascular causes. There were no deaths. In multivariate logistic regression analysis, the high-risk SDoH group had a higher odds ratio for all-cause hospitalization (OR 5.31, 95% CI 1.59-17.73). In addition, Kansas City Cardiomyopathy Questionnaire 12-item (KCCQ-12) scores, surrogate for quality of life, were worse in the high-risk SDoH group.

Conclusion

SDoH adversely impacts hospitalizations and quality of life in women with heart failure. Future efforts for screening and interventions should evaluate the SDoH at all levels, including the individual health care provider, institutional, and national levels.

目的健康的社会决定因素(SDoH)占慢性疾病(如心力衰竭)健康结果可改变因素的80%-90%。关于SDoH如何影响心力衰竭妇女的住院率存在知识空白。我们的目的是评估心力衰竭妇女的基线SDoH状况与随后的全因和心血管住院之间的关系。方法:这是一项前瞻性观察性纵向队列研究,对诊断为心力衰竭的女性进行了6个月的随访。受试者完成了医学研究所的SDoH评估。每月随访以评估住院事件。结果共纳入92例患者,随访至少1次。平均年龄66±15岁,80%的患者因非缺血性心肌病导致心力衰竭。纽约心脏协会(NYHA)分类I-II最常见(n = 66, 71.8%)。总共有51例患者(55.4%)具有总体高危SDoH(4个或更多SDoH域处于危险中)。随访6个月时,22例(23.9%)患者因各种原因住院;8例(8.7%)因心血管原因住院。没有人员死亡。在多因素logistic回归分析中,SDoH高危组的全因住院优势比更高(OR 5.31, 95% CI 1.59-17.73)。此外,堪萨斯城心肌病问卷12项(KCCQ-12)评分,替代生活质量,在高危SDoH组更差。结论sdoh对心力衰竭患者的住院率和生活质量有不利影响。未来在筛查和干预方面的努力应在各个层面评估健康状况,包括个人卫生保健提供者、机构和国家层面。
{"title":"Social Determinants of Health in Women With Heart Failure: Prospective Observational Cohort Study","authors":"Dae Hyun Lee ,&nbsp;Vidhi Patel ,&nbsp;Nicholas Mencer ,&nbsp;Sasha Ann East ,&nbsp;Nhi Tran ,&nbsp;Theresa Beckie ,&nbsp;Janice Zgibor ,&nbsp;Joel Fernandez","doi":"10.1016/j.ajmo.2023.100047","DOIUrl":"10.1016/j.ajmo.2023.100047","url":null,"abstract":"<div><h3>Objective</h3><p>The social determinants of health (SDoH) account for 80%-90% of modifiable contributors to health outcomes for chronic diseases such as heart failure. Knowledge gaps exist on how SDoH influences hospitalization rates in women with heart failure. Our aim was to evaluate the relationship between the baseline SDoH status of women with heart failure with subsequent all-cause and cardiovascular hospitalization.</p></div><div><h3>Methods</h3><p>This is a prospective observational longitudinal cohort study of women diagnosed with heart failure with 6-month follow-up. The subjects completed SDoH assessment by the Institute of Medicine. Monthly follow-ups were performed to assess for hospitalization events.</p></div><div><h3>Results</h3><p>A total of 92 patients with at least 1 follow-up clinic visit were included. The mean age was 66 ± 15 years and 80% had nonischemic cardiomyopathy as the etiology of heart failure. New York Heart Association (NYHA) Classifications I-II were the most common (<em>n</em> = 66, 71.8%). In total, 51 patients (55.4%) had overall high-risk SDoH (4 or more SDoH domains at risk). By the 6-month follow-up, 22 (23.9%) patients were hospitalized for any cause; 8 patients (8.7%) were hospitalized for cardiovascular causes. There were no deaths. In multivariate logistic regression analysis, the high-risk SDoH group had a higher odds ratio for all-cause hospitalization (OR 5.31, 95% CI 1.59-17.73). In addition, Kansas City Cardiomyopathy Questionnaire 12-item (KCCQ-12) scores, surrogate for quality of life, were worse in the high-risk SDoH group.</p></div><div><h3>Conclusion</h3><p>SDoH adversely impacts hospitalizations and quality of life in women with heart failure. Future efforts for screening and interventions should evaluate the SDoH at all levels, including the individual health care provider, institutional, and national levels.</p></div>","PeriodicalId":72168,"journal":{"name":"American journal of medicine open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48188924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and Laboratory Correlates of QTc Duration in Adult and Pediatric Sickle Cell Disease 成人和儿童镰状细胞病QTc持续时间的临床和实验室相关性
Pub Date : 2023-06-12 DOI: 10.1016/j.ajmo.2023.100045
Xue Yu , Suvankar Majumdar , J. Daryl Pollard , Erin Jackson , Jarrod Knudson , Douglas Wolfe , Gregory J. Kato , Joseph F. Maher

Background

Sickle cell disease, a common genetic disorder in African Americans, manifests an increased risk of sudden death, the basis of which is incompletely understood. Prolongation of heart rate–corrected QT (QTc) interval on the electrocardiogram, a standard clinical measure of cardiac repolarization, may contribute to sudden death by predisposing to torsades de pointes ventricular tachycardia.

Methods

We established a cohort study of 293 adult and 121 pediatric sickle cell disease patients drawn from the same geographic region as the Jackson Heart Study (JHS) cohort, in which significant correlates of QT duration have been characterized and quantitatively modeled. Herein, we establish clinical and laboratory correlates of QTc duration in our cohort using stepwise multivariate linear regression analysis. We then compared our adult sickle cell disease data to effect-size predictions from the published JHS statistical model of QT interval duration.

Results

In adult sickle cell disease, gender, diuretic use, QRS duration, serum ALT levels, anion gap, and diastolic blood pressure show positive correlation; hemoglobin levels show inverse correlation; in pediatric sickle cell disease, age, hemoglobin levels, and serum bicarbonate and creatinine levels show inverse correlation. The mean QTc in our adult sickle cell disease cohort is 7.8 milliseconds longer than in the JHS cohort, even though the JHS statistical model predicts that the mean QTc in our cohort should be >11 milliseconds shorter than in the much older JHS cohort, a differential of >18 milliseconds.

Conclusion

Sickle cell disease patients have substantial QTc prolongation relative to their age, driven by factors, some overlapping, in adult and pediatric sickle cell disease, and distinct from those that have been defined in the general African American community.

背景镰状细胞病是非裔美国人常见的遗传病,其猝死风险增加,其基础尚不完全清楚。心电图上心率校正QT(QTc)间期的延长,作为心脏复极的标准临床测量,可能会导致尖端扭转型室性心动过速,从而导致猝死。方法我们对293名成人和121名儿童镰状细胞病患者进行了队列研究,这些患者来自与杰克逊心脏研究(JHS)队列相同的地理区域,其中QT间期的显著相关性已经得到了表征和定量建模。在此,我们使用逐步多元线性回归分析在我们的队列中建立QTc持续时间的临床和实验室相关性。然后,我们将我们的成人镰状细胞病数据与已发表的QT间期持续时间JHS统计模型的效应大小预测进行了比较。结果成人镰状细胞病患者性别、利尿剂使用、QRS波持续时间、血清ALT水平、阴离子间隙、舒张压呈正相关;血红蛋白水平呈负相关;在儿童镰状细胞病中,年龄、血红蛋白水平、血清碳酸氢盐和肌酐水平呈负相关。尽管JHS统计模型预测我们的成年镰状细胞病队列中的平均QTc应该>;与年龄大得多的JHS队列相比短11毫秒;18毫秒。结论镰状细胞病患者的QTc随着年龄的增长而显著延长,这是由成人和儿童镰状细胞疾病的因素驱动的,有些因素是重叠的,与一般非裔美国人社区中定义的患者不同。
{"title":"Clinical and Laboratory Correlates of QTc Duration in Adult and Pediatric Sickle Cell Disease","authors":"Xue Yu ,&nbsp;Suvankar Majumdar ,&nbsp;J. Daryl Pollard ,&nbsp;Erin Jackson ,&nbsp;Jarrod Knudson ,&nbsp;Douglas Wolfe ,&nbsp;Gregory J. Kato ,&nbsp;Joseph F. Maher","doi":"10.1016/j.ajmo.2023.100045","DOIUrl":"https://doi.org/10.1016/j.ajmo.2023.100045","url":null,"abstract":"<div><h3>Background</h3><p>Sickle cell disease, a common genetic disorder in African Americans, manifests an increased risk of sudden death, the basis of which is incompletely understood. Prolongation of heart rate–corrected QT (QTc) interval on the electrocardiogram, a standard clinical measure of cardiac repolarization, may contribute to sudden death by predisposing to <em>torsades de pointes</em> ventricular tachycardia.</p></div><div><h3>Methods</h3><p>We established a cohort study of 293 adult and 121 pediatric sickle cell disease patients drawn from the same geographic region as the Jackson Heart Study (JHS) cohort, in which significant correlates of QT duration have been characterized and quantitatively modeled. Herein, we establish clinical and laboratory correlates of QTc duration in our cohort using stepwise multivariate linear regression analysis. We then compared our adult sickle cell disease data to effect-size predictions from the published JHS statistical model of QT interval duration.</p></div><div><h3>Results</h3><p>In adult sickle cell disease, gender, diuretic use, QRS duration, serum ALT levels, anion gap, and diastolic blood pressure show positive correlation; hemoglobin levels show inverse correlation; in pediatric sickle cell disease, age, hemoglobin levels, and serum bicarbonate and creatinine levels show inverse correlation. The mean QTc in our adult sickle cell disease cohort is 7.8 milliseconds longer than in the JHS cohort, even though the JHS statistical model predicts that the mean QTc in our cohort should be &gt;11 milliseconds shorter than in the much older JHS cohort, a differential of &gt;18 milliseconds.</p></div><div><h3>Conclusion</h3><p>Sickle cell disease patients have substantial QTc prolongation relative to their age, driven by factors, some overlapping, in adult and pediatric sickle cell disease, and distinct from those that have been defined in the general African American community.</p></div>","PeriodicalId":72168,"journal":{"name":"American journal of medicine open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49715274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Screening for Hereditary Hemochromatosis in Newly Referred Diabetes Mellitus 新发糖尿病遗传性血色素沉着症的筛查
Pub Date : 2023-06-09 DOI: 10.1016/j.ajmo.2023.100046
Michael Lockhart, Muhammad Ridhwaan Salehmohamed, Dileep Kumar, Anne Graham Cummiskey, Keat Cheah Seong, Seamus Sreenan, John McDermott

Aims

Hereditary hemochromatosis (HH) is the most common inherited disease in European populations. It is particularly common in people of Irish heritage, approximately 2% of whom will be at risk of iron overload as a result of human homoeostatic iron regulator protein (HFE) gene mutations. We aimed to evaluate the utility of screening for HH in newly referred patients with DM of Irish heritage in a prospective study.

Methods

Of 575 patients newly referred between March 2018 and March 2021, 556 attended for blood testing, to include fasting transferrin saturations, prior to their first clinic visit. Patients with elevated transferrin saturations were further screened for hereditary hemochromatosis (HH) with HFE gene analysis.

Results

Transferrin saturations were elevated in 13 of 556 patients (2.3%), 3 of whom had a preexisting diagnosis of HH. Of the remaining 10 patients, 7 had HFE gene mutations suggestive of HH (2 C282Y homozygous, 3 C282Y/H63D compound heterozygous, and 2 H63D homozygous), 1 was a HH carrier (C282Y heterozygous), and 2 had normal genetics.

Conclusions

The prevalence of HH of 1.8% in this screened DM population is lower than the reported incidence of HH in the Irish population, suggesting a limited utility of routine screening for HH in newly referred patients with DM.

遗传性血色素沉着病(HH)是欧洲人群中最常见的遗传性疾病。它在爱尔兰血统的人中尤其常见,其中约2%的人将因人类等位铁调节蛋白(HFE)基因突变而面临铁过载的风险。在一项前瞻性研究中,我们旨在评估新转诊的爱尔兰裔糖尿病患者进行HH筛查的效用。方法在2018年3月至2021年3月期间新转诊的575名患者中,556人在首次就诊前接受了血液检测,包括空腹转铁蛋白饱和度。用HFE基因分析进一步筛选转铁蛋白饱和度升高的患者是否患有遗传性血色素沉着症(HH)。结果556例患者中有13例(2.3%)转铁蛋白饱和度升高,其中3例已有HH诊断。在其余10名患者中,7名患者的HFE基因突变提示HH(2名C282Y纯合子,3名C282Y/H63D复合杂合子,2名H63D纯合子),1名患者为HH携带者(C282Y杂合子),2名患者遗传正常。结论在该筛查的糖尿病人群中,HH的患病率为1.8%,低于爱尔兰人群中报告的HH发病率,这表明常规筛查在新转诊的糖尿病患者中的作用有限。
{"title":"Screening for Hereditary Hemochromatosis in Newly Referred Diabetes Mellitus","authors":"Michael Lockhart,&nbsp;Muhammad Ridhwaan Salehmohamed,&nbsp;Dileep Kumar,&nbsp;Anne Graham Cummiskey,&nbsp;Keat Cheah Seong,&nbsp;Seamus Sreenan,&nbsp;John McDermott","doi":"10.1016/j.ajmo.2023.100046","DOIUrl":"https://doi.org/10.1016/j.ajmo.2023.100046","url":null,"abstract":"<div><h3>Aims</h3><p>Hereditary hemochromatosis (HH) is the most common inherited disease in European populations. It is particularly common in people of Irish heritage, approximately 2% of whom will be at risk of iron overload as a result of human homoeostatic iron regulator protein (<em>HFE</em>) gene mutations. We aimed to evaluate the utility of screening for HH in newly referred patients with DM of Irish heritage in a prospective study.</p></div><div><h3>Methods</h3><p>Of 575 patients newly referred between March 2018 and March 2021, 556 attended for blood testing, to include fasting transferrin saturations, prior to their first clinic visit. Patients with elevated transferrin saturations were further screened for hereditary hemochromatosis (HH) with <em>HFE</em> gene analysis.</p></div><div><h3>Results</h3><p>Transferrin saturations were elevated in 13 of 556 patients (2.3%), 3 of whom had a preexisting diagnosis of HH. Of the remaining 10 patients, 7 had <em>HFE</em> gene mutations suggestive of HH (2 C282Y homozygous, 3 C282Y/H63D compound heterozygous, and 2 H63D homozygous), 1 was a HH carrier (C282Y heterozygous), and 2 had normal genetics.</p></div><div><h3>Conclusions</h3><p>The prevalence of HH of 1.8% in this screened DM population is lower than the reported incidence of HH in the Irish population, suggesting a limited utility of routine screening for HH in newly referred patients with DM.</p></div>","PeriodicalId":72168,"journal":{"name":"American journal of medicine open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49714985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American journal of medicine open
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1